# Tpex Subsets in Negative Tumor Draining Lymph Nodes for Predicting the Efficacy of PD 1 Inhibitors in Advanced or Recurrent Esophageal Squamous Cell Carcinoma

> **NCT07533357** · — · NOT_YET_RECRUITING · sponsor: **Fudan University** · enrollment: 158 (estimated)

## Conditions studied

- Esophageal Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07533357
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-20
- **Primary completion:** 2029-04-06
- **Final completion:** 2029-04-06
- **Target enrollment:** 158 (ESTIMATED)
- **Last updated:** 2026-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07533357

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07533357, "Tpex Subsets in Negative Tumor Draining Lymph Nodes for Predicting the Efficacy of PD 1 Inhibitors in Advanced or Recurrent Esophageal Squamous Cell Carcinoma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07533357. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*